McNeil Imodium Patent Prosecution Conduct Leads To Perrigo Fee Award
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer & Specialty Pharmaceuticals' "irresponsible" conduct in prosecuting "obvious" patent claims relating to Imodium Advanced justifies awarding Perrigo attorneys' fees in a patent infringement case, a Philadelphia federal judge ruled June 25